sonographic marker for NACT in our study. Proper treatment selection is necessary based on the patients' performance status, imaging criteria and laboratory parameters in order to provide optimal patient tailored treatment with minimal morbidity.
Objectives:
To develop an ultrasound-based score for predicting debulking surgery outcome in advanced stage ovarian cancer. Methods: Retrospective analysis of data from a prospective cohort study comprising 65 women with surgically confirmed stage IIB-IV epithelial ovarian cancer. All women underwent transabdominal/transvaginal ultrasound evaluation for assessing disease spread prior to surgery. 12 anatomical areas were evaluated for the presence/absence of disease. All women included underwent surgery at our institution (diagnostic laparoscopy followed by upfront surgery if patient deemed adequate for optimal (R<1cm) or complete (R0) cytoreduction). Surgical findings and permanent frozen section histologic diagnosis were used as reference standard. The score was developed according to the odd ratio (for optimal or complete cytoreduction) for each anatomical area and CA-125 serum levels ( Results: Cytoreduction was complete or optimal in 51 patients (78.5%), suboptimal in 3 (4.6%) and upfront surgery was discarded in 11 women (16.9%). A score ≥ 3 predicted correctly 44 out 51 patients (86%) with complete/optimal cytoreduction in and 8 out of 14 (57%) of those with suboptimal or non-cytoreduction surgery. AUC was 0.76, with correct prediction in 80% of all cases. Conclusions: Albeit the series is small, the developed ultrasound-based score has a good performance for predicting surgical results in IIB-IV stage epithelial ovarian cancer. Objectives: To describe sonographic features of the microcystic elongated and fragmented (MELF) pattern of myometrial invasion (MI) using the International Endometrial Tumor Analysis (IETA) criteria; to assess the effect of the MELF pattern on preoperative ultrasound evaluation of MI; and to determine the relationship of the MELF pattern to more advanced stage (≥ IB) and lymph node metastases (LNM) in women with endometrioid endometrial cancer (EEC). Methods: We included 850 women with EEC from the prospective IETA 4 study. Ultrasound experts performed all ultrasound examinations, according to the IETA protocol. Reference pathologists assessed the presence or absence of the MELF pattern. Sonographic features and accuracy of ultrasound assessment of MI were compared in cases with the presence and the absence of the MELF pattern. The MELF pattern was correlated to more advanced stage (≥IB) and LNM. Results: The MELF pattern was present in 197 (23.2%) women. On preoperative ultrasound imaging the endometrium was thicker (p = 0.031), more richly vascularised (p = 0.003) with the multiple multifocal vessel pattern (p < 0.001) and the assessment of adenomyosis was more often uncertain (p < 0.001). The presence or the absence of the MELF pattern did not affect the accuracy of the assessment of MI. The MELF pattern was associated with MI ≥ 50% (p < 0.001), cervical stromal invasion (CSI) (p = 0.037), more advanced stage (≥ IB) (p < 0.001) and LNM (p = 0.011). Conclusions: Tumours with the MELF pattern were slightly larger, more richly vascularised with multiple multifocal vessels and assessment of adenomyosis was more uncertain on ultrasound imaging. The MELF pattern did not increase the risk of underestimating MI in preoperative ultrasound staging. Tumours with the MELF pattern were more than twice as likely to have more advanced stage (≥ IB) and LNM.
